In the Media Tag: vaxent


2015 a Big Year for Memphis Health Community

The Daily News

Vaxent chief scientific officer James B. Dale, who also serves as a professor of medicine and chief of the division of infectious diseases at the University of Tennessee Health Science Center, invented the vaccine based on more than 25 years of laboratory research.


StreptAnova® Phase 1 clinical trial to start: Vaccine designed to prevent Streptococcus pyogenes infections

In the Media Icon

StreptAnova® was invented by James B. Dale, M.D., Chief of the Division of Infectious Diseases, and Gene H. Stollerman, M.D., Endowed Professor in Medicine at the University of Tennessee Health Science Center (UTHSC), and Research Scientist at the Memphis Veterans Affairs Medical Center. It is being commercialized jointly by PREVENT and Vaxent, a company founded… Read More


Streptococcus Vaccine Clinical Trial to Begin

StreptAnova® was invented by Dr. James B. Dale at the University of Tennessee Health Science Center (UTHSC), and is being commercialized jointly by PREVENT and Vaxent, a company founded by Dr. Dale.


Streptococcus Vaccine Clinical Trial to Begin

In the Media Icon

StreptAnova® was invented by Dr. James B. Dale at the University of Tennessee Health Science Center (UTHSC), and is being commercialized jointly by PREVENT and Vaxent, a company founded by Dr. Dale.